
Academic Journal
Q2Asia-Pacific Journal of Clinical Oncology
About Asia-Pacific Journal of Clinical Oncology
Asia-Pacific Journal of Clinical Oncology is a scholarly journal published by Wiley-Blackwell Publishing Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.565 and H-index of 49.
Coverage: 2006-2026. Research categories: Medicine (miscellaneous) (Q2); Oncology (Q3).
Source-backed journal facts
Topics in published research
Diverse Scientific and Economic Studies; Human auditory perception and evaluation; Multiple and Secondary Primary Cancers; Economic and Financial Impacts of Cancer; Lung Cancer Treatments and Mutations; Advances in Oncology and Radiotherapy.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,700.00 USD; 3,070.00 EUR; 2,510.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
ANZSA Annual Scientific Meeting
2026-10 · DOI: 10.1111/ajco.70181Author Index
2026-10 · DOI: 10.1111/ajco.70197NRF2‐Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities
Suleiman Ibrahim Mohammad, Asokan Vasudevan, Samreet Raizal Rodrigues, Rustam Turakulov et al.
2026-09-27 · DOI: 10.1111/ajco.70195Treatment Outcomes in Nasopharyngeal Carcinoma Treated With Intensity‐Modulated Radiotherapy Versus 3D‐Conformal Radiotherapy Techniques: A Single‐Center Experience in a Developing Country
Pooria Mousavi, Ali Kazemian, Ehsan Saraee, Mahdi Aghili et al.
2026-09-27 · DOI: 10.1111/ajco.70196Nimotuzumab Combined With Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma: A Systematic Review and Meta‐Analysis
Chengzheng Bao, Yue Zhang, Xiang Fei, Kaifeng Ji et al.
2026-09-16 · DOI: 10.1111/ajco.70178Implementation and Management of Cancer Clinical Quality Registries in Australia: A Qualitative Study
Ashleigh R. Sharman, Jonathan R. Clark, Rebecca L. Venchiarutti
2026-09-12 · DOI: 10.1111/ajco.70182Real‐World Experience of Cabozantinib in Relapsed Osteosarcoma and Ewing Sarcoma—A Single Center Retrospective Study
Jiaxing Jason Qin, Susie Bae, Stephen J. Luen, Anne Hamilton et al.
2026-09-11 · DOI: 10.1111/ajco.70180Issue Information
2026-10 · DOI: 10.1111/ajco.70131Augmented Reality, Mixed Reality, Virtual Reality, and Extended Reality Applications in Personalized Oncology and Patient‐Centered Cancer Care: A Narrative Review
Malarkodi Velraj, Deepalakshmi Mani, Arun Kanniyappan Parthasarathy, Vijayakumar Murugesan et al.
2026-09-09 · DOI: 10.1111/ajco.70172From Interest to Care: Closing the Psycho‐Oncology Loop in Advanced Cancer
Po‐Jung Hsueh, Lien‐Chung Wei
2026-09-09 · DOI: 10.1111/ajco.70179The Experience of Mandarin‐Speaking Radiotherapy Patients Using an Instant Language Translation Device to Facilitate Communication
Darren Hunter, Nigel Anderson, Richard Oates, David Kok et al.
2026-09-09 · DOI: 10.1111/ajco.70175Immune Checkpoint Inhibitor‐Associated Acute Kidney Injury: A Single‐Centre Study
Jyothirmaye Kuppa, Nitesh Rao, Rajiv Juneja, Caroline Milton et al.
2026-09-09 · DOI: 10.1111/ajco.70174Disparities in the Burden of Prostate Cancer and Its Trends in the Western Pacific Region, 1990–2021
Lei Wu, Shijia Yang, Guohong Zhu, Yao Liu et al.
2026-09-07 · DOI: 10.1111/ajco.70173METTL3 Promotes the Growth of Triple‐Negative Breast Cancer Cells by Modulating Ferroptosis‐Related Oxidative Stress via the ELF1/GPX4 Axis
Jincheng Wang, Wei Wang, Junjie Hu, Guanghui Wang et al.
2026-09-07 · DOI: 10.1111/ajco.70171Comprehensive Genomic Profiling Timeliness Beyond Laboratory Turnaround Time: A Patient‐Facing Pathway Analysis
Shinya Kajiura, Naohiko Nakamura, Ryuji Hayashi
2026-09-03 · DOI: 10.1111/ajco.70176CDK4/6 Inhibitors in the Management of Hormone Receptor‐Positive (HR+)/Human Epidermal Growth Factor Receptor 2‐Negative (HER2−) Advanced Breast Cancer in Indonesia: Challenges, Opportunities, and Recommendations
Sonar Soni Panigoro, Samuel J. Haryono, Prihantono Prihantono, Dedy Hermansyah et al.
2026-09-01 · DOI: 10.1111/ajco.70168The International Conference on New Models for Cancer Prevention and Treatment (NMCPT 2026)
2026-09 · DOI: 10.1111/ajco.70156Author Index
2026-09 · DOI: 10.1111/ajco.70157Reviews
Community Reviews
Version History
October 4, 2026 at 9:14 pm
October 2, 2026